Although NTZ was first reported as an autophagy inhibitor and induced cell cycle arrest in GBM by upregulating ING1 (p33) expression (Wang et al., 2018), it is intrinsically linked with our finding that CDK1 is a target of TIZ. The gene discussed is CDK1; the disease is glioblastoma.